$Relationship between controlled attenuated parameter and magnetic resonance imaging–proton density fat fraction for evaluating hepatic steatosis in patients with NAFLD$

Relationship between controlled attenuated parameter and magnetic resonance imaging–proton density fat fraction for evaluating hepatic steatosis in patients with NAFLD

Abstract We used cross‐sectional and longitudinal studies to comprehensively compare hepatic steatosis measurements obtained with magnetic resonance imaging–proton density fat fraction (MRI‐PDFF) and controlled attenuated parameter (CAP) in hepatic steatosis in adults with nonalcoholic fatty liver d...

Full description

Bibliographic Details
Main Authors:	Ziming An, Qiaohong Liu, Wenli Zeng, Yan Wang, Qian Zhang, Huafu Pei, Xin Xin, Shuohui Yang, Fang Lu, Yu Zhao, Yiyang Hu, Qin Feng
Format:	Article
Language:	English
Published:	Wolters Kluwer Health/LWW 2022-08-01
Series:	Hepatology Communications
Online Access:	https://doi.org/10.1002/hep4.1948

Similar Items

Comparison of sonographic hepatorenal ratio and the degree of hepatic steatosis in magnetic resonance imaging-proton density fat fraction
by: Tanpowpong Natthaporn, et al.
Published: (2020-01-01)

Correlation between magnetic resonance imaging proton density fat fraction (MRI-PDFF) and liver biopsy to assess hepatic steatosis in obesity
by: Pornphan Wibulpolprasert, et al.
Published: (2024-03-01)

Reliability of ultrasound hepatorenal index and magnetic resonance imaging proton density fat fraction techniques in the diagnosis of hepatic steatosis, with magnetic resonance spectroscopy as the reference standard.
by: Bien Van Tran, et al.
Published: (2021-01-01)

Afriplex GRTTM extract attenuates hepatic steatosis in an in vitro model of NAFLD
by: Kwazi Gabuza, et al.
Published: (2024-01-01)

Comparison of Multimaterial Decomposition Fat Fraction with DECT and Proton Density Fat Fraction with IDEAL IQ MRI for Quantification of Liver Steatosis in a Population Exposed to Chemotherapy
by: Giuseppe Corrias, et al.
Published: (2021-04-01)

Proton density fat fraction: magnetic resonance imaging applications beyond the liver
by: Ilkay S. Idilman, et al.
Published: (2022-01-01)

Fucoidan and Fucoxanthin Attenuate Hepatic Steatosis and Inflammation of NAFLD through Modulation of Leptin/Adiponectin Axis
by: Ping-Hsiao Shih, et al.
Published: (2021-03-01)

Malonylation of Acetyl-CoA carboxylase 1 promotes hepatic steatosis and is attenuated by ketogenic diet in NAFLD
by: Huanyi Cao, et al.
Published: (2023-04-01)

Diagnostic Performance of Ultrasound in Detecting Hepatic Steatosis in Non-Alcoholic Fatty Liver Disease Considering MRI Proton Density Fat Fraction as the Reference Standard
by: Ankita Aggarwal, et al.
Published: (2024-01-01)

Comparison between magnetic resonance and ultrasound-derived indicators of hepatic steatosis in a pooled NAFLD cohort.
by: Cayden Beyer, et al.
Published: (2021-01-01)

Laboratory parameters in lean NAFLD: comparison of subjects with lean NAFLD with obese subjects without hepatic steatosis
by: Philipp Bernhardt, et al.
Published: (2018-02-01)

Marked difference in liver fat measured by histology vs. magnetic resonance-proton density fat fraction: A meta-analysis
by: Sami Qadri, et al.
Published: (2024-01-01)

Non-invasive assessment of hepatic steatosis in patients with NAFLD using controlled attenuation parameter and 1H-MR spectroscopy.
by: Thomas Karlas, et al.
Published: (2014-01-01)

Association Between Low Muscle Mass and Non-alcoholic Fatty Liver Disease Diagnosed Using Ultrasonography, Magnetic Resonance Imaging Derived Proton Density Fat Fraction, and Comprehensive NAFLD Score in Korea
by: Hun Ju Lee, et al.
Published: (2021-11-01)

Transient elastography with controlled attenuation parameter versus two-dimensional shear wave elastography with attenuation imaging for the evaluation of hepatic steatosis and fibrosis in NAFLD
by: Jung Wook Seo, et al.
Published: (2023-07-01)

Fructus Xanthii attenuates hepatic steatosis in rats fed on high-fat diet.
by: Xiumin Li, et al.
Published: (2013-01-01)

Accuracy of attenuation coefficient measurement (ACM) for real-time ultrasound hepatic steatometry: Comparison of simulator/phantom data with magnetic resonance imaging proton density fat fraction (MRI-PDFF)
by: Nazarii Kobyliak, et al.
Published: (2023-10-01)

<i>Tremella fuciformis</i> Crude Polysaccharides Attenuates Steatosis and Suppresses Inflammation in Diet-Induced NAFLD Mice
by: Tariq Jamal Khan, et al.
Published: (2022-03-01)

(Pro)Renin Receptor Antagonism Attenuates High-Fat-Diet–Induced Hepatic Steatosis
by: Ariana Julia B. Gayban, et al.
Published: (2023-01-01)

Selenoneine Ameliorates Hepatocellular Injury and Hepatic Steatosis in a Mouse Model of NAFLD
by: Masaaki Miyata, et al.
Published: (2020-06-01)

Follistatin Alleviates Hepatic Steatosis in NAFLD via the mTOR Dependent Pathway
by: Tong J, et al.
Published: (2022-10-01)

Acupuncture improved hepatic steatosis in HFD-induced NAFLD rats by regulating intestinal microbiota
by: Haiying Wang, et al.
Published: (2023-03-01)

Iron metabolism mediates the relationship between Vitamin C and hepatic steatosis and fibrosis in NAFLD
by: Zhengyu Hu, et al.
Published: (2022-09-01)

A Computational Model of Hepatic Energy Metabolism: Understanding Zonated Damage and Steatosis in NAFLD.
by: William B Ashworth, et al.
Published: (2016-09-01)

Feasibility of Hepatic Fat Quantification Using Proton Density Fat Fraction by Multi-Echo Chemical-Shift-Encoded MRI at 7T
by: Radim Kořínek, et al.
Published: (2021-05-01)

Associations Between Vertebral Marrow Proton Density Fat Fraction and Risk of Prostate Cancer
by: Shaojun Li, et al.
Published: (2022-04-01)

Oxygenated Water Inhibits Adipogenesis and Attenuates Hepatic Steatosis in High-Fat Diet-Induced Obese Mice
by: Yuh-Jen Cheng, et al.
Published: (2020-07-01)

Effect of orlistat on liver fat content in patients with nonalcoholic fatty liver disease with obesity: assessment using magnetic resonance imaging-derived proton density fat fraction
by: Junzhao Ye, et al.
Published: (2019-09-01)

Equol, a metabolite of gut microbiota, attenuates liver steatosis via the SIRT1/HNF4α pathway in NAFLD mice
by: Zhizhong Luo, et al.
Published: (2023-08-01)

Protective Effects of Gnetin C from Melinjo Seed Extract against High-Fat Diet-Induced Hepatic Steatosis and Liver Fibrosis in NAFLD Mice Model
by: Tohfa Kabir, et al.
Published: (2023-09-01)

Tetrahydroxanthohumol, a xanthohumol derivative, attenuates high-fat diet-induced hepatic steatosis by antagonizing PPARγ
by: Yang Zhang, et al.
Published: (2021-06-01)

l-Fucose ameliorates high-fat diet-induced obesity and hepatic steatosis in mice
by: Guangyan Wu, et al.
Published: (2018-12-01)

Magnetic Resonance Imaging-Proton Density Fat Fraction vs. Transient Elastography-Controlled Attenuation Parameter in Diagnosing Non-alcoholic Fatty Liver Disease in Children and Adolescents: A Meta-Analysis of Diagnostic Accuracy
by: Shuangzhen Jia, et al.
Published: (2022-01-01)

Histone demethylase KDM1A promotes hepatic steatosis and inflammation by increasing chromatin accessibility in NAFLD
by: Zifeng Yang, et al.
Published: (2024-03-01)

Vitamin D improves hepatic steatosis in NAFLD via regulation of fatty acid uptake and β-oxidation
by: Tingwan Du, et al.
Published: (2023-03-01)

The relationship between Lipocalin-2 level and hepatic steatosis in obese patients with NAFLD after bariatric surgery
by: Jiaqi Chen, et al.
Published: (2022-01-01)

Piceatannol attenuates fat accumulation and oxidative stress in steatosis-induced HepG2 cells
by: Jason Szuhao Yang, et al.
Published: (2020-11-01)

Dietary açai attenuates hepatic steatosis via adiponectin-mediated effects on lipid metabolism in high-fat diet mice
by: Joyce Ferreira da Costa Guerra, et al.
Published: (2015-04-01)

Weight-loss-independent benefits of exercise on liver steatosis and stiffness in Japanese men with NAFLD
by: Sechang Oh, et al.
Published: (2021-06-01)

Discordance diagnosis between B-mode ultrasonography and MRI proton density fat fraction for fatty liver
by: Chul-min Lee, et al.
Published: (2023-09-01)